Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Grifols SA PRF Perpetual EUR 0.05 - Class B is a perpetual preferred stock issued by Grifols, S.A., a leading global specialty plasma therapeutics company headquartered in Barcelona, Spain. This Class B security, with a par value of 0.05 euros and ISIN ES0171996095, provides investors with a fixed dividend preference without a maturity date, emphasizing stable income generation. Grifols develops, manufactures, and distributes plasma-derived protein therapies that treat life-threatening conditions such as immunological deficiencies, hemophilia, chronic inflammatory demyelinating polyneuropathy, and infectious diseases. The majority of its revenue originates from the United States, supported by an extensive network of plasma collection centers worldwide. As non-voting shares listed alongside Class A shares, these preferred shares play a key role in Grifols' capital structure, offering priority dividend payments—recently around 1.93% yield—and contributing to the company's financing for expansion in healthcare innovation and manufacturing infrastructure.